» Articles » PMID: 17761946

The Transcription Factor Snail Mediates Epithelial to Mesenchymal Transitions by Repression of Estrogen Receptor-alpha

Overview
Journal Mol Endocrinol
Date 2007 Sep 1
PMID 17761946
Citations 111
Authors
Affiliations
Soon will be listed here.
Abstract

The estrogen receptor (ER)-alpha (ESR1) is a key regulatory molecule in mammary epithelial cell development. Loss of ER-alpha in breast cancer is correlated with poor prognosis, increased recurrence after treatment, and an elevated incidence of metastasis. A proposed molecular pathway by which ER-alpha acts to constrain invasive growth in breast cancer cells involves direct, ER-alpha-dependent expression of metastasis-associated protein 3, a cell-type-specific component of the Mi-2/NuRD chromatin remodeling complex. MTA3 in turn represses expression of Snail, a transcription factor linked to epithelial to mesenchymal transition and cancer metastasis. To elucidate its role(s) in epithelial to mesenchymal transition (EMT), we expressed Snail in the noninvasive, ER-alpha-positive MCF-7 cell line. Snail expression led to decreased cell-cell adhesion and increased cell invasiveness. Furthermore, we observed loss of ER-alpha expression at both the RNA and protein level that was accompanied by direct interaction of Snail with regulatory DNA sequences at the ESR1 locus. A consequence of loss of ER-alpha function in this system was the increased abundance of key components of the TGF-beta signaling pathway. Thus, cross-talk among ER-alpha, Snail, and the TGF-beta pathway appears to control critical phenotypic properties of breast cancer cells.

Citing Articles

Breast cancer cell resistance to hormonal and targeted therapeutics is correlated with the inactivation of the NR6A1 axis.

Andreeva O, Sorokin D, Vinokurova S, Kopnin P, Elkina N, Katargin A Cancer Drug Resist. 2024; 7:48.

PMID: 39624078 PMC: 11609143. DOI: 10.20517/cdr.2024.69.


Regulation of ERα-dependent breast cancer metastasis by a miR-29a signaling.

Lu J, Zhao Q, Guo Y, Li D, Xie H, Liu C J Exp Clin Cancer Res. 2023; 42(1):93.

PMID: 37081505 PMC: 10116798. DOI: 10.1186/s13046-023-02665-6.


Effects of Combined Pentadecanoic Acid and Tamoxifen Treatment on Tamoxifen Resistance in MCF-7/SC Breast Cancer Cells.

To N, Truong V, Ediriweera M, Cho S Int J Mol Sci. 2022; 23(19).

PMID: 36232636 PMC: 9570034. DOI: 10.3390/ijms231911340.


ATAC-seq Optimization for Cancer Epigenetics Research.

Cooper M, Ray A, Bhattacharya A, Dhasarathy A, Takaku M J Vis Exp. 2022; (184).

PMID: 35848835 PMC: 10064075. DOI: 10.3791/64242.


Role of cellular reprogramming and epigenetic dysregulation in acquired chemoresistance in breast cancer.

Ponnusamy L, Mahalingaiah P, Chang Y, Singh K Cancer Drug Resist. 2022; 2(2):297-312.

PMID: 35582717 PMC: 8992622. DOI: 10.20517/cdr.2018.11.


References
1.
Nibu Y, Zhang H, Bajor E, Barolo S, Small S, Levine M . dCtBP mediates transcriptional repression by Knirps, Krüppel and Snail in the Drosophila embryo. EMBO J. 1998; 17(23):7009-20. PMC: 1171049. DOI: 10.1093/emboj/17.23.7009. View

2.
Larriba M, Munoz A . SNAIL vs vitamin D receptor expression in colon cancer: therapeutics implications. Br J Cancer. 2005; 92(6):985-9. PMC: 2361934. DOI: 10.1038/sj.bjc.6602484. View

3.
Cui X, Schiff R, Arpino G, Osborne C, Lee A . Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. J Clin Oncol. 2005; 23(30):7721-35. DOI: 10.1200/JCO.2005.09.004. View

4.
Ottaviano Y, Issa J, Parl F, Smith H, Baylin S, Davidson N . Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res. 1994; 54(10):2552-5. View

5.
Lehnertz B, Ueda Y, Derijck A, Braunschweig U, Perez-Burgos L, Kubicek S . Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol. 2003; 13(14):1192-200. DOI: 10.1016/s0960-9822(03)00432-9. View